Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody.

Literature DB >> 1678821

Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody.

J Emmrich, M Seyfarth, W E Fleig, F Emmrich.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 1991 PMID： 1678821 DOI： 10.1016/0140-6736(91)91133-f

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

Review 1. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Authors: Jochen Maul; Martin Zeitz
Journal: Langenbecks Arch Surg Date: 2011-04-09 Impact factor: 3.445

Review 2. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.

Authors: Bojana Simovic Markovic; Tatjana Kanjevac; C Randall Harrell; Marina Gazdic; Crissy Fellabaum; Nebojsa Arsenijevic; Vladislav Volarevic
Journal: Stem Cell Rev Rep Date: 2018-04 Impact factor: 5.739

Review 3. Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Authors: M J Weldon; J D Maxwell
Journal: Gut Date: 1994-07 Impact factor: 23.059

Review 4. Biologic therapy for inflammatory bowel disease.

Authors: Sandro Ardizzone; Gabriele Bianchi Porro
Journal: Drugs Date: 2005 Impact factor: 9.546

5. Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cells.

Authors: Stephan Fricke; Nadja Hilger; Christian Fricke; Uta Schönfelder; Gerhard Behre; Peter Ruschpler; Andreas Boldt; Christopher Oelkrug; Ulrich Sack; Frank Emmrich
Journal: Cell Mol Life Sci Date: 2013-09-26 Impact factor: 9.261

Review 6. Principles of antibody therapy.

Authors: S J Russell; M B Llewelyn; R E Hawkins
Journal: BMJ Date: 1992-12-05

Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody.

Review 1. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Review 2. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.

Review 3. Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

Review 4. Biologic therapy for inflammatory bowel disease.

5. Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cells.

Review 6. Principles of antibody therapy.

7. Specific CTL activity of CD8+ TCR Vbeta14+ T cell in mouse 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis.

Review 8. Immunomodulator therapy in inflammatory bowel disease.

9. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.

10. Biologic targeting in the treatment of inflammatory bowel diseases.